JPRN-UMIN000040581已完成未知
A single-arm, open-label, intervention study to investigate the improvement of glucose tolerance after administration of the 5-aminolevulinic acid (5-ALA) in the patients with mitochondrial diabetes mellitus - 5-ALA study of mitochondrial diabetes mellitus
agasaki University Hospital0 个研究点目标入组 5 人开始时间: 2020年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who have previously taken 5-ALA/SFC within 8 weeks. 2. Patients treated with metformin. 3. Patients with a history of porphyria, hemochromatosis, or viral hepatitis. 4. Women who are currently pregnant or will not be compliant with a medically approved contraceptive regimen during the study period and lactating women. Men who will not be compliant with a contraceptive regimen during the study period. 5. Patients participated in another clinical study within 4 months. 6. Patients whom the investigator considered inappropriate to participating this trial.
研究者
相似试验
进行中（未招募）
1 期
Open-label, single arm, interventional study to explore the efficacy and safety of paliperidone ER in the management of patients with acute agitation and/or aggression - IMPACTEUCTR2009-015629-35-BEJanssen-Cilag NV/SA
尚未招募
2 期
An interventional study to evaluate the effect of syrup mutra sangrahaneeya mahakashaya in participients of childhood nephrotic syndrome.CTRI/2024/07/069889O SPONSER
招募中
2 期
Romiplostim in Inherited marrow failure syndromes - Safety and EfficacyCTRI/2024/03/063966INDIAN COUNCIL OF MEDICAL RESEARCH
已完成
不适用
An open-label, low interventional clinical study investigating error rates (critical and overall) prior to any retraining in correct use of the ELLIPTA dry powder inhaler (DPI) compared to other DPIs including; DISKUS, Turbuhaler, HandiHaler and Breezhaler as a monotherapy or in combination, in adult patients with Chronic Obstructive Pulmonary Disease (COPD) (study 204981)chronic obstructive airways disease (COPD)10038716NL-OMON46129GlaxoSmithKline360
尚未招募
Unknown
Evaluation of a Novel Continuous Glucose Monitoring System in Children and Adults with Type 1 and Type 2 DiabetesType 2 diabetesMetabolic and Endocrine - DiabetesType 1 diabetesACTRN12624000735550i-SENS, Inc.100